Valuation: AstraZeneca PLC

Market Cap 263B 230B 212B 195B 369B 25,295B 376B 2,531B 993B 12,364B 987B 966B 42,614B P/E 2026 *
21.2x
P/E 2027 * 18.6x
Enterprise Value 282B 247B 228B 209B 396B 27,142B 403B 2,716B 1,066B 13,266B 1,059B 1,036B 45,725B EV / Sales 2026 *
4.46x
EV / Sales 2027 * 4.11x
Free-Float
96.63%
Yield 2026 *
1.97%
Yield 2027 * 2.08%

Last Transcript: AstraZeneca PLC

1 day-0.21%
1 week-6.17%
Current month-11.13%
1 month-5.68%
3 months-15.69%
6 months-10.83%
Current year-9.14%
1 week 9,892
Extreme 9892
13,414
1 month 9,892
Extreme 9892
15,126
Current year 9,892
Extreme 9892
15,732
1 year 9,892
Extreme 9892
15,732
3 years 9,461
Extreme 9461
15,732
5 years 8,029
Extreme 8029
15,732
10 years 3,996
Extreme 3996
15,732
Manager TitleAgeSince
Chief Executive Officer 66 2012-09-30
Director of Finance/CFO 52 2021-07-31
Compliance Officer - 2022-12-31
Director TitleAgeSince
Director/Board Member 70 1999-04-05
Director/Board Member 66 2012-09-30
Director/Board Member 65 2017-04-26
Date Insider Type Main position Quantity % Market Cap.
Jul. 05Free

See Remarks

2 0.0000%
Jun. 07Free

See Remarks

1 0.0000%
May. 19Sell

See Remarks

-11,893 0.0008%
Change 5-day change 1-year change 3-year change Capi.($)
-0.23%-6.17%+20.07%+22.84% 263B
+1.84%-3.54%+48.63%+162.53% 1,031B
+1.67%-2.86%+52.74%+58.22% 595B
+2.81%-0.12%+30.98%+85.13% 431B
-0.36%-1.70%+28.73%+22.97% 326B
+0.63%-1.13%+29.21%+44.72% 277B
+1.84%+5.19%-22.34%-37.17% 224B
+2.10%+0.71%+22.47%+60.73% 193B
+1.49%-1.31%+21.14%+71.75% 164B
+1.87%+3.98%+2.46%-29.68% 141B
Average +1.30%-3.09%+23.41%+46.20% 364.58B
Weighted average by Cap. +1.44%-4.02%+33.13%+75.65%

Financials

2026 *2027 *
Net sales 63.22B 55.27B 50.99B 46.87B 88.81B 6,083B 90.32B 609B 239B 2,973B 237B 232B 10,248B 66.81B 58.41B 53.88B 49.53B 93.85B 6,428B 95.45B 643B 252B 3,142B 251B 245B 10,830B
Net income 12.43B 10.87B 10.03B 9.22B 17.46B 1,196B 17.76B 120B 46.97B 585B 46.69B 45.66B 2,015B 13.94B 12.18B 11.24B 10.33B 19.58B 1,341B 19.91B 134B 52.65B 655B 52.34B 51.19B 2,259B
Net Debt 19.2B 16.78B 15.48B 14.23B 26.96B 1,847B 27.43B 185B 72.52B 903B 72.09B 70.51B 3,112B 11.9B 10.41B 9.6B 8.82B 16.72B 1,145B 17.01B 115B 44.97B 560B 44.7B 43.72B 1,929B
Logo AstraZeneca PLC
AstraZeneca PLC is one of the world's leading pharmaceutical groups. Net sales break down by source of income as follows: - product sales (99.8%). Net sales break down by treatment area between oncology (42.6%), cardiovascular, renal and metabolic diseases (23%), respiratory and autoimmune diseases (14.7%), and other (19.7%; inflammatory diseases, neurological diseases, gastrointestinal and infectious diseases); - collaboration revenue (0.2). Net sales are distributed geographically as follows: the United Kingdom (7.4%), Europe (22.9%), the United States (40.8%), Americas (6.1%) and Africa/Asia/Australia (22.8%).
Employees
96,100
Date Price Change Volume
26-07-16 GBX 12,576.00 +0.08% 603,070
26-07-15 GBX 12,566.00 +1.63% 3,346,169
26-07-14 GBX 12,364.00 -1.95% 3,313,274
26-07-13 GBX 12,610.00 -1.75% 2,741,916
26-07-10 GBX 12,834.00 -3.89% 3,355,019
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
24
Last Close Price
169.49USD
Average target price
212.17USD
Spread / Average Target
+25.18%

Quarterly revenue - Rate of surprise